Cytokinetics To Present Phase IIa Clinical Trials Data On CK-1827452 At The 2009 Heart Failure Congress Of The European Society Of Cardiology

Main Category: Cardiovascular / Cardiology
Also Included In: Clinical Trials / Drug Trials
Article Date: 26 May 2009 - 0:00 PDT

email to a friend   printer friendly   opinions  

Cytokinetics, Incorporated (NASDAQ: CYTK) announced that data relating to two Phase IIa clinical trials evaluating CK-1827452, one in stable heart failure patients and one in patients with ischemic cardiomyopathy and angina, are scheduled to be presented in two poster presentations and in the late breaking trials session at the 2009 Heart Failure Congress of the European Society of Cardiology, to be held May 30-June 2, 2009, at the Nice Acropolis Palais des Congrès et Expositions in Nice, France.

Late Breaking Trials Session

The late breaking presentation titled "The Selective Cardiac Myosin Activator, CK-1827452, Increases Systolic Function in Heart Failure" will be presented on Monday, June 1, 2009 from 11:00 AM - 12:30 PM Central European Time in the Apollon Auditorium by John Cleland, MD, FACC, FRCP, FESC, Professor of Cardiology, Castle Hill Hospital, University of Hull, United Kingdom.

Poster Presentations

Program #149: "Echocardiographic Detection of Increases in Ejection Fraction in Patients with Heart Failure Receiving the Selective Cardiac Myosin Activator, CK-1827452" is scheduled to be displayed in the session titled "Medical and Surgical Treatments Poster Session: Drug Therapy, Other" on Sunday, May 31, 2009 from 8:30 AM - 12:30 PM Central European Time in the Clinical Poster Zone. The poster will be moderated by Jonathan H. Goldman, MD, FACC, Chief Medical Officer, ICON Medical Imaging, Warrington, PA from 10:00 AM - 11:00 AM.

Program #174: "Phase II Safety Study Evaluating the Novel Cardiac Myosin Activator, CK-1827452, in Patients with Ischemic Cardiomyopathy and Angina" is scheduled to be displayed in the session titled "Medical and Surgical Treatments Poster Session: Drug Therapy, Other" on Sunday, May 31, 2009 from 8:30 AM - 12:30 PM Central European Time in the Clinical Poster Zone. The poster will be moderated by Barry H. Greenberg, MD, Chair of the Safety Review Committee for this clinical trial and Director, Advanced Heart Failure Treatment Program, University of California, San Diego Medical Center from 10:00 AM - 11:00 AM.

Source
Cytokinetics

• Additional
• References
• Citations